Your body naturally produces a number of substances that affect your appetite. One of these is called GLP-1. GLP-1 is a hormone that is produced when you eat. It stops you from feeling hungry and makes you feel full. It also improves your body’s ability to regulate blood sugar levels.
Semaglutide and/or Tirzepatide reduces feelings of hunger which means you eat less food. This helps to reduce your body weight when combined with a healthy diet and exercise.
Semaglutide and/or Tirzepatide has been shown to stop the progression of plaques in blood vessels in studies of animals.
If your blood sugar levels are too high, Semaglutide and/or Tirzepatide helps to lower them.
Not everyone will experience side effects, but if you do, you should let the study staff know. The most commonly reported side effects are stomach and gut problems. These may include feeling sick (nausea) or being sick (vomiting), diarrhea, upset stomach, low appetite, pain in the stomach area, and constipation. These side effects are usually mild or moderate. They are most likely to happen when you first start taking the study medicine and are likely to decrease or disappear entirely as you continue through the study. To decrease the chances of you having stomach and gut side effects, you will be started on a low dose of the study medicine, which will be increased gradually.